Evidence map›Paper›PMID 26597909›Full record

ArticleStem cell research & therapy2015

Nanochelating based nanocomplex, GFc7, improves quality and quantity of human mesenchymal stem cells during in vitro expansion.

Maryam Hafizi, Atena Hajarizadeh, Amir Atashi, Somayeh Kalanaky, Saideh Fakharzadeh, Zahra Masoumi, Mohammad Hassan Nazaran, Masoud Soleimani

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maryam HafiziStem Cell Technology Research Center, Tehran, Iran. mhafizi@nanochelatingtechnology.com.
Atena HajarizadehStem Cell Technology Research Center, Tehran, Iran. athena.hajarizadeh@gmail.com.
Amir AtashiDepartment of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. atashia@gmail.com.
Somayeh KalanakyDepartment of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran. skalanaky@nanochelatingtechnology.com.
Saideh FakharzadehDepartment of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran. sfakharzade@nanochelatingtechnology.com.
Zahra MasoumiStem Cell Technology Research Center, Tehran, Iran. zahra.masoumi@yahoo.com.
Mohammad Hassan NazaranDepartment of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran. mnazaran@nanochelatingtechnology.com.
Masoud SoleimaniDepartment of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. soleim_m@modares.ac.ir.
Stem Cell Technology Research Center · IRTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHuman mesenchymal stem cells (hMSCs) have been approved for therapeutic applications. Despite the advances in this field, in vitro approaches are still required to improve the essential indices that would pave the way to a bright horizon for an efficient transplantation in the future. Nanotechnology could help to improve these approaches. Studies signified the important role of iron in stem cell metabolism and efficiency of copper chelation application for stem cell expansion

methodsFor the first time, based on novel Nanochelating technology, we design an iron containing copper chelator nano complex, GFc7 and examined on hMSCs during in vitro expansion. In this study, the hMSCs were isolated, characterized and expanded in vitro in two media (with or without GFc7). Then proliferation, cell viability, cell cycle analysis, surface markers, HLADR, pluripotency genes expression, homing and antioxidative defense at genes and protein expression were investigated. Also we analyzed the spontaneous differentiation and examined osteogenic and lipogenic differentiation.

resultsGFc7 affected the expression of key genes, improving both the stemness and fitness of the cells in a precise and balanced manner. We observed significant increases in cell proliferation, enhanced expression of pluripotency genes and homing markers, improved antioxidative defense, repression of genes involved in spontaneous differentiation and exposing the hMSCs to differentiation medium indicated that pretreatment with GFc7 increased the quality and rate of differentiation.

conclusionsThus, GFc7 appears to be a potential new supplement for cell culture medium for increasing the efficiency of transplantation.

Indexed as

Cell Culture TechniquesChelating AgentsNanospheresAntigens, DifferentiationAntioxidantsCell DifferentiationCell ProliferationCell SurvivalCopperCulture MediaHumansIron Chelating AgentsMesenchymal Stem CellsPluripotent Stem CellsAntigens, DifferentiationAntioxidantsChelating AgentsCopperCulture MediaIron Chelating Agents

Identifiers

PMID26597909
PMCPMC4657224
OpenAlexW2177165745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.